Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World March 22, 2012 Andrew Turley	GSK to build 350 million factory in UK GlaxoSmithKline has announced plans to build its first new UK production plant for almost 40 years in Ulverston, Cumbria.
Pharmaceutical Executive December 1, 2011	UK Report: Keep Calm and Carry On ... Differently Even as the global economic roller coaster affects one of the country's dearest public institutions, the National Health Service, there is still reason for optimism in these times of austerity.
Chemistry World March 4, 2013 Andy Extance	UK considers patent rule change for trials The UK has announced plans to amend aspects of its patent law that may be encouraging pharma companies to run their clinical trials in other countries.
Chemistry World March 20, 2008 Richard Van Noorden	UK Drug Firms to Slash Research and Jobs The UK pharmaceutical industry is expecting to cut jobs and investment in R&D following an alarming slump in confidence in the UK market.
Chemistry World April 29, 2014 Phillip Broadwith	Pfizer courts AstraZeneca megamerger US-based pharma behemoth Pfizer has publically announced its intention to make a merger offer to the UK's AstraZeneca, in a deal valued at around $100 billion.
Chemistry World December 8, 2011 Sarah Houlton	Academia Grows Its Role in Drug Discovery The number of pharma patents being filed by universities around the world is soaring compared with those coming from industry.
Chemistry World February 2, 2012 Andrew Turley	AstraZeneca to cut 7300 more jobs UK drugmaker AstraZeneca has announced plans to cut a further 7300 jobs to make annual savings of $1.6 billion by the end of 2014, a move that will cost the company $2.1 billion in the near term.
Chemistry World February 4, 2010 Matt Wilkinson	More pharma R&D budget cuts GlaxoSmithKline (GSK) and Pfizer are both following AstraZeneca's lead in cutting their research and development budgets.
Pharmaceutical Executive August 1, 2005 Jill Wechsler	Washington Report: Treating Patents It may seem unusual that a court ruling challenging patent protections is considered a victory for Big Pharma. But the decision was supported by pharmaceutical companies, along with the Justice Department, as a way to spur biomedical research and new-drug development.
Inc. July 24, 2002 Jennifer A. Redmond	Strategic Patenting What to consider when you're filing a patent and strategic decisions you'll need to make.
Wall Street & Technology September 19, 2006 Paul Allen	Patent Processing For both the patent holders and potential transgressors, technology patents can be a high-stakes game in the financial world, in both monetary awards and ongoing business feasibility.
Chemistry World October 1, 2008 Victoria Gill	GSK to Cut 850 R&D Jobs GlaxoSmithKline has announced that up to 850 R&D jobs will be cut as it implements its new business strategy.
InternetNews January 11, 2007 Clint Boulton	IBM Leads 2006 Patent Hike IBM banks 3,651 patents as the industry sees a better than 20 percent upswing in patent grants over 2005.
Chemistry World March 8, 2011 Andy Extance	GSK will pay off UK graduate tuition fees Potential undergraduate chemistry students concerned about their prospects in the face of plant closures and increased tuition fees have been given some cheer by pharmaceutical giant GlaxoSmithKline.
Chemistry World March 7, 2008 Peter Mitchell	Uk Drug Pricing System Scrapped The UK government is scrapping its existing national scheme for controlling drug prices. The system, called the Pharmaceutical price regulation scheme (PPRS), will be replaced by a newly negotiated agreement on 1 September 2008.
Chemistry World July 11, 2012	Europe-Wide Single Patent Stalls Again A single European patent is on the wish list of small innovative businesses.
Chemistry World September 10, 2015 Matthew Gunther	Research bodies urge UK government to protect science funding Nearly 200 research organizations have signed an open letter urging the UK government to protect science funding in the 2015 UK spending review.
Chemistry World June 24, 2011 Andrew Turley	Pfizer to Keep 350 Jobs at Sandwich US drug giant Pfizer has said that it will keep 350 jobs at its site in Sandwich, UK.
Chemistry World March 9, 2011 Andrew Turley	Court halts EU patent progress The intellectual property community will have to wait a little longer for its one-size-fits-all European patent, following a key ruling from the Court of Justice of the European Union
Chemistry World January 28, 2010 Nina Notman	AstraZeneca's workforce slashed again Pharma giant AstraZeneca is to cut another 8,000 jobs globally over the next four years - with approximately 1,800 additional research and development staff to be lost.
Chemistry World February 2, 2007 Victoria Gill	AstraZeneca Follows Pfizer in Slashing Workforce The Anglo-Swedish pharmaceutical hopes that by streamlining its operation it can offset the growing financial threat from cheap generic copies of its best-selling blood pressure drug. Nevertheless, the company has reported unexpectedly cheerful fourth quarter profits.
Chemistry World November 9, 2010 Andrew Turley	Stanford to challenge patent rights in Supreme Court The US Supreme Court has agreed to rule on the question of who owns intellectual property generated using billions of dollars of taxpayer money for medical research.
The Motley Fool June 1, 2007 Brian Lawler	The Generic Cracks Open for Pfizer Pfizer loses a patent case over its top compound. The larger takeaway from the Lipitor legal saga is that investors always need to be aware of the strength of a drug company's patents throughout the world.
CFO December 1, 2011 Marielle Segarra	Putting a Price on Patents CFOs can play a critical role in bringing financial discipline to their companies' intellectual-property portfolios.
Chemistry World May 4, 2006 Katharine Sanderson	Cancer Charity Takes on Shelved Drugs Cancer Research UK, and its commercial arm, Cancer Research Technology have launched a clinical development partnership scheme to sweep up drug candidates that pharmaceuticals companies have deprioritized for not showing enough commercial promise.
BusinessWeek December 13, 2004 Bruce Einhorn	Go East, Big Pharma Drugmakers are expanding in China, but patents are still a worry.
Chemistry World August 7, 2012 Anthony King	Irish pharma exports tumble Irish pharma exports to the US declined 30% in the first six months of this year as a clatter of blockbuster drugs made in Ireland, such as Lipitor (atorvastatin), came off patent.
Chemistry World January 18, 2012 Patrick Walter	Shell shutters UK R&D site The research currently carried out at the facility will be transferred to overseas sites. The announcement has fueled concerns in the UK research community that the country's opportunity to become a high-tech economy is slipping away.
IEEE Spectrum February 2006 Lee A. Hollaar	Patents 2.0 There are big problems with patents, especially software patents. A new type of patent is needed -- Congress should create a new, limited protection that protects against knockoffs without overreaching.
Chemistry World December 22, 2011 Sarah Houlton	Pharma braces for patent cliff impact It remains to be seen quite how far Lipitor sales will fall. Ranbaxy has six months of exclusivity for generic competition.
HBS Working Knowledge June 9, 2008 Sean Silverthorne	Monetizing IP: The Executive's Challenge In this Q&A, Harvard Business School professor Josh Lerner discusses current trends in Intellectual property, including the rise of patent pools.
Pharmaceutical Executive September 1, 2010	Looking Beyond the Patent Cliff Pfizer's VP and Assistant General Counsel for Global Patents and Policy, Roy Waldron, discusses its collaborative strategy to refresh the face of IP.
Information Today June 10, 2002 Nancy Lambert	Patent Express: The End of an Era Patent information is a growth industry these days, and customers are demanding inexpensive access to international as well as U.S. patent documents.
CIO January 1, 2003 Christopher Koch	Patently Stupid? It's not clear at the start of 2003 whether the software patent frenzy will cause innovation to flower or be trampled.
Chemistry World May 14, 2014 Andy Extance	Pfizer presses hard for AstraZeneca deal US pharma giant Pfizer is battling a backlash of suspicion and hostility across the world over its attempts to acquire its UK-headquartered rival AstraZeneca.
Chemistry World December 13, 2013 Maria Burke	UK overtakes US on research quality metric The UK has overtaken the US and now ranks first in one indicator of research quality, according to a new report commissioned by the UK's Department of Business, Innovation and Skills.
The Motley Fool September 28, 2006 Jack Uldrich	IBM's Patently Good Idea Big Blue's decision to open patents to public scrutiny could spur innovation.
InternetNews September 27, 2006 Michael Hickins	IBM Pushes New Patent Policies Patent reform may be on the way, but IBM has decided to change the system on its own and is leading by example.
Chemistry World September 8, 2010 Andrew Turley	Vince Cable: science cuts are coming Taxpayers should only back research that makes money or is academically exceptional, UK business secretary Vince Cable said today in his first speech on science.
IndustryWeek December 1, 2008 Jill Jusko	Litigation Nation: By the Numbers Patent infringement claims bedevil manufacturers, survey finds.
CFO February 1, 2011	Any More Bright Ideas? Test your knowledge of IP ASAP.
Chemistry World October 2006	Head to Head For: Patents protect inventions by giving the owner of the patent the right to stop anyone from making or using the invention without the owner's permission... Against: Patents are a menace...
Chemistry World September 14, 2007 Peter Mitchell	European Patents Set to Get Cheaper Patents valid across many European countries will soon be much easier and cheaper to register, with the coming into force of the so-called London Agreement.
Bank Technology News July 2008 Glen Fest	IP Practices Core to Patent Strategy John Cronin, managing director of ipCapital Group, but best known as the founder of IBM's "Patent Factory," says banks themselves are to blame for their patent predicament.
IndustryWeek October 1, 2007 Jill Jusko	Patent Protection Your valuable intellectual property requires keen oversight. To help keep it safe, consider these actions.
The Motley Fool April 27, 2006 Stephen D. Simpson	Investors Get Starry-Eyed for AstraZeneca Investors, while this British drug giant is getting its due from the market now in response to strong earnings, positive guidance, and more confidence in the future portfolio of drugs, remember to do your own due diligence first.
Chemistry World July 10, 2013 Darren Smyth	How to invent and protect your invention Even as an account of US patent law, this book, by Kennedy et al., has little to commend it. It is difficult to understand in many places, the selection of topics for coverage is peculiar, and is downright wrong in many details.
BusinessWeek July 9, 2007 Lorraine Woellert	Look Who's Fighting Patent Reform VCs, trade groups, and universities have taken up the fight against Big Tech's efforts to rewrite U.S. patent law.
IEEE Spectrum December 2005 Steven J. Frank	Patent Reform Cacophy The Patent Reform Act may, in the end, merely contribute another layer of cost, delay, and uncertainty.
Chemistry World April 16, 2010 Sean Milmo	Ineos starts UK chemicals exodus Ineos's decision to relocate its headquarters to Switzerland because of corporate taxation concerns may spark an exodus of chemical and pharmaceutical companies from having their headquarters in the UK.